Director Share Dealing

Alliance Pharma PLC
16 May 2005


For Immediate Release                                              16 May 2005



                               ALLIANCE PHARMA PLC

                      ('Alliance Pharma' or 'the Company')



                            Director's Share Dealing



Alliance Pharma plc (AIM: APH), an emerging speciality pharmaceutical company,
is pleased to announce that Michael Gatenby, Chairman of Alliance Pharma plc,
purchased 50,000 shares at 14.45p, bringing his total in the company to 130,000
shares which represents 0.088% of the total issued share capital.






For further information:


Alliance Pharma plc                                         + 44 (0) 1249 466966
John Dawson, Chief Executive
Maddy Scott, Finance Director
www.alliancepharma.co.uk

Buchanan Communications                                    + 44 (0) 20 7466 5000
Mark Court/Lisa Baderoon/Rebecca Skye Dietrich





Notes to editors



About Alliance Pharma

Alliance Pharma, founded in 1996, is an AIM listed emerging speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The company has a
strong track record of acquiring the rights to established niche brands and
owns, or shares, the rights to 30 branded pharmaceutical products and continues
to explore opportunities to expand the range.



Alliance Pharma's products are prescribed in the treatment of a wide range of
conditions and include brands used in the prevention of heart disease, in
Parkinson's disease, in nutrition, in nasal infections, in the treatment of
dermatological conditions and in childbirth.  Alliance Pharma's sales are mainly
prescription driven.  Its products are distributed to hospitals directly and to
pharmaceutical wholesalers which service both hospital and retail pharmacies
with

their prescription requirements. Alliance Pharma is also developing new products
for sleep disorders and the induction of labour.



Alliance Pharma joined the AIM market of the London Stock Exchange in December
2003 and trades under the symbol APH.






                      This information is provided by RNS
            The company news service from the London Stock Exchange